Assessing the impact of a safe and equitable biosimilar policy in the United States : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Tenth Congress, first session, May 2, 2007

• Descrizione fisica: 1 online resource (vi, 184 p.) : ill
• Soggetto topico: Biologicals - United States; Pharmaceutical biotechnology - United States; Generic drugs - United States
• Soggetto non controllato: Biologicals; Pharmaceutical biotechnology; Generic drugs; Medical; Technology & engineering
• Altri titoli varianti: Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States
• Titolo autorizzato: Assessing the impact of a safe and equitable biosimilar policy in the United States
• Formato: Materiale a stampa
• Livello bibliografico: Monografia
• Lingua di pubblicazione: Inglese
• Record Nr.: 9910694419603321
• Lo trovi qui: Univ. Federico II